PDS Biotechnology Corp: 10-Q filed 2016-08-03
What PDS Biotechnology Corp reported in its quarterly report filed 2016-08-03 (fiscal Q2 2016): 25 published measures, 65 facts as tagged in accession 0001140361-16-074623.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-08-03
- Fiscal period
- fiscal Q2 2016
- Accession
- 0001140361-16-074623 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PDS Biotechnology Corp filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 115,419,833 | USD | |
| At 2015-12-31 | 134,092,658 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 106,756,104 | USD | |
| At 2015-12-31 | 122,477,527 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 111,022,034 | USD | |
| At 2015-12-31 | 130,189,421 | USD | |
| At 2015-06-30 | 58,465,083 | USD | |
| At 2014-12-31 | 13,728,972 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -9,376,129 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -18,546,539 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -5,520,963 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -9,989,448 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 195,317 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 447,170 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | -80,800,509 | USD | |
| At 2015-12-31 | -62,253,970 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 3,461,121 | USD | |
| At 2015-12-31 | 2,766,992 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 2,796,296 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 954,684 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -9,264,195 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -18,296,555 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -4,960,309 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -9,142,578 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 111,815,842 | USD | |
| At 2015-12-31 | 131,270,505 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 161,310 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 342,174 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 211,863 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 402,026 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 6,763,927 | USD | |
| At 2015-12-31 | 8,589,708 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 2,854,796 | USD | |
| At 2015-12-31 | 2,584,249 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 9,264,195 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 18,296,555 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 4,960,309 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 9,142,578 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 5,975,306 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 11,322,069 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 3,195,244 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 6,066,483 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 28,849,446 | shares | |
| At 2015-12-31 | 28,810,845 | shares |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 4,359,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 142,870 | USD | |
| At 2015-12-31 | 55,161 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 1,519,909 | USD | |
| At 2015-12-31 | 3,734,348 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-06-30 | 793,808 | USD | |
| At 2015-12-31 | 1,081,084 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -9,376,129 | USD | 91 |
| 2015-04-01 to 2015-06-30 | -5,520,963 | USD | 91 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | -9,376,129 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -18,546,539 | USD | 182 |
| 2015-04-01 to 2015-06-30 | -7,267,297 | USD | 91 |
| 2015-01-01 to 2015-06-30 | -12,418,963 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-04-01 to 2016-06-30 | 3,288,889 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 6,974,486 | USD | 182 |
| 2015-04-01 to 2015-06-30 | 1,765,065 | USD | 91 |
| 2015-01-01 to 2015-06-30 | 3,076,095 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 31,689 | USD | 182 |
| 2015-01-01 to 2015-06-30 | 23,714 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-06-30 | 289,820 | USD | 182 |
| 2015-01-01 to 2015-06-30 | -1,202,721 | USD | 181 |
Inspect the source
- Entity
- PDS Biotechnology Corp / CIK 0001472091
- Captured
- 2026-09-20T09:07:40.584Z
- SEC response SHA-256
69e1cee7a201b49964a3008a5c2ec76eaaf5723c75824c2caf8a2c52d86edef2
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001472091.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))